Beyond cell-autonomous effects, NF-κB hyperactivation remodels the bone marrow niche by upregulating IL-6 and MCL1 to sustain MM proliferation while stimulating receptor activator of nuclear factor-κB Ligand (RANKL) secretion to promote osteoclast-mediated bone destruction [14]. Here, NFKB1 is linked to Miyoshi myopathy.